It’s time to unsheath your swords as a new Bleach-like experience, called Paradox, finally arrives on Roblox. Before you can upgrade your skills and parry enemies into a devastating blow, you will ...

Credit: VentureBeat made with OpenAI ChatGPT-Images-2.0 Anthropic co-founder and CEO Dario Amodei said it was coming, but it still feels like a milestone: More than 80% of the code merged into ...

AI vulnerability scanning is moving into developer workflows. Claude Security turns findings into prioritized fix guidance. The big challenge is keeping these tools from attackers. Anthropic has ...

Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred We are more connected than ever before, with ...

The workplace can be a tricky place to navigate. Almost everything we do at work—identifying the experts, managing tough feedback from a boss, figuring out how to work in teams made up of different ...

The growing use of generative artificial intelligence (GenAI) tools for coding is transforming software engineering practices, with developers now building continuous integration and continuous ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...